Literature DB >> 8631848

Modulation of interferon (IFN)-inducible gene expression by retinoic acid. Up-regulation of STAT1 protein in IFN-unresponsive cells.

V Kolla1, D J Lindner, W Xiao, E C Borden, D V Kalvakolanu.   

Abstract

Interferons (IFN) and retinoids failed to inhibit the growth of a number of breast tumor cell lines. However, a combination of these two biological response modifiers significantly suppressed the cell growth at pharmacologically achievable doses. The molecular basis for such enhancement was investigated in MCF-7, a breast tumor cell line resistant to growth inhibition by IFN-beta. Pretreatment of cells with retinoic acid (RA) for 16 h followed by IFN-beta, but not the converse, induced cytotoxic effects in the cells. Continuous presence of RA was not necessary, although it enhanced the degree of cell death when present. Further analyses revealed that IFN-beta failed to activate IFN-stimulated gene transcription. However, IFN-beta strongly up-regulated the gene expression in RA-pretreated cells. Both IFN-beta- and IFN-gamma-inducible gene expression were enhanced via a modulation of the transcriptional factor IFN-stimulated gene factors-3 and GAF binding to respective cognate regulatory elements. STAT1 was undetectable in these cells prior to RA treatment. RA increased the levels of this crucial regulator, thereby restoring IFN responses. Thus, RA augmentation of STAT1 may be an early step in the cooperative anti-tumor effects of IFN and RA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631848     DOI: 10.1074/jbc.271.18.10508

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Tripartite motif 24 (Trim24/Tif1α) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα) inhibition.

Authors:  Johan Tisserand; Konstantin Khetchoumian; Christelle Thibault; Doulaye Dembélé; Pierre Chambon; Régine Losson
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

Review 2.  STAT signaling in the pathogenesis and treatment of cancer.

Authors:  D A Frank
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

3.  Tamoxifen enhances interferon-regulated gene expression in breast cancer cells.

Authors:  D J Lindner; V Kolla; D V Kalvakolanu; E C Borden
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

4.  RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation.

Authors:  Lin-Jia Jiang; Nan-Nan Zhang; Fei Ding; Xian-Yang Li; Lei Chen; Hong-Xin Zhang; Wu Zhang; Sai-Juan Chen; Zhu-Gang Wang; Jun-Min Li; Zhu Chen; Jiang Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-11       Impact factor: 11.205

5.  Transcriptional regulation of the human Na/K ATPase via the human mineralocorticoid receptor.

Authors:  V Kolla; G Litwack
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

Review 6.  Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer.

Authors:  M Widschwendter; J Berger; H M Müller; A G Zeimet; C Marth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

7.  Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees.

Authors:  Catherine B Bigger; Bernadette Guerra; Kathleen M Brasky; Gene Hubbard; Michael R Beard; Bruce A Luxon; Stanley M Lemon; Robert E Lanford
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL.

Authors:  Nicole Clarke; Ana M Jimenez-Lara; Emilie Voltz; Hinrich Gronemeyer
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

9.  Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses.

Authors:  Jennifer Zurney; Kristina E Howard; Barbara Sherry
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

10.  Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation.

Authors:  Jian Zheng; Xudong Huang; Wen Tan; Dianke Yu; Zhongli Du; Jiang Chang; Lixuan Wei; Yaling Han; Chengfeng Wang; Xu Che; Yifeng Zhou; Xiaoping Miao; Guoliang Jiang; Xianjun Yu; Xianghong Yang; Guangwen Cao; Chaohui Zuo; Zhaoshen Li; Chunyou Wang; Siu Tim Cheung; Yongfeng Jia; Xiongwei Zheng; Hongbing Shen; Chen Wu; Dongxin Lin
Journal:  Nat Genet       Date:  2016-05-23       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.